Risk of bevacizumab-associated gastrointestinal perforation in patients with colorectal cancer and noncolorectal cancer

被引：0
|
作者：
Chu, D. T. [1 ]
Hapani, S. [1 ]
Wu, S. [1 ]
机构：
[1] Stony Brook Univ Hosp, Stony Brook, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9622
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Bevacizumab-associated gastrointestinal perforation
    Chau, Ian
    Cunningham, David
    LANCET ONCOLOGY, 2009, 10 (06): : 534 - 536
  • [2] Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer
    Fang, Kunpeng
    Wang, Jie
    Yuan, Jianyong
    Sui, Chengjun
    Zhi, Jiajun
    Xia, Yong
    Sun, Minmin
    CANCER REPORTS, 2024, 7 (02)
  • [3] Bevacizumab-Associated Fistula Formation in Postoperative Colorectal Cancer Patients
    Ganapathi, Asvin M.
    Westmoreland, Tammy
    Tyler, Douglas
    Mantyh, Christopher R.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 214 (04) : 582 - 588
  • [4] Clinical predictors of bevacizumab-associated gastrointestinal perforation
    Tanyi, Janos L.
    McCann, Georgia
    Hagemann, Andrea R.
    Coukos, George
    Rubin, Stephen C.
    Liao, John B.
    Chu, Christina S.
    GYNECOLOGIC ONCOLOGY, 2011, 120 (03) : 464 - 469
  • [5] Bevacizumab-Associated Fistula Formation in Postoperative Colorectal Cancer Patients Discussion
    Guillem, Jose
    Pemberton, John
    O'Leary, Patrick
    Cole, David
    Papaconstantinou, Harry
    Duncan, Mark
    Mantyh, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 214 (04) : 588 - 590
  • [6] Gastrointestinal Perforation Due to Bevacizumab in Colorectal Cancer
    Muhammad Wasif Saif
    Aymen Elfiky
    Ronald R. Salem
    Annals of Surgical Oncology, 2007, 14 : 1860 - 1869
  • [7] Gastrointestinal perforation due to bevacizumab in colorectal cancer
    Saif, Muhammad Wasif
    Elfiky, Aymen
    Salem, Ronald R.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (06) : 1860 - 1869
  • [8] Incidence and management of bevacizumab-associated gastrointestinal perforation in patients with recurrent ovarian carcinoma
    Diaz, J. P.
    Zivanovic, O.
    Tew, W. P.
    Konner, J.
    Sabbatini, P. J.
    Abu-Rustum, N. R.
    Chi, D. S.
    Aghajanian, C.
    Barakat, R. R.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S137 - S137
  • [9] Bevacizumab-associated intestinal perforation and perioperative complications in patients receiving bevacizumab
    Yoshimoto, Toshiaki
    Yoshikawa, Kozo
    Higashijima, Jun
    Miyatani, Tomohiko
    Tokunaga, Takuya
    Nishi, Masaaki
    Takasu, Chie
    Kashihara, Hideya
    Takehara, Yukako
    Shimada, Mitsuo
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2020, 4 (02): : 151 - 155
  • [10] Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab
    Aflah Roohullah
    Hui-Li Wong
    Katrin M Sjoquist
    Peter Gibbs
    Kathryn Field
    Ben Tran
    Jeremy Shapiro
    Joe Mckendrick
    Desmond Yip
    Louise Nott
    Val Gebski
    Weng Ng
    Wei Chua
    Timothy Price
    Niall Tebbutt
    Lorraine Chantrill
    World Journal of Gastroenterology, 2015, (17) : 5352 - 5358
12345